超越血小板计数:评估脾切除术后ITP患者使用TPO-RA的安全性
该回顾性队列研究纳入2011至2024年间接受脾切除术的88例成人ITP患者,其中37例(42%)术后使用TPO-RA。TPO-RA组血栓发生17例 vs 非TPO-RA组14例(P=0.07),10年累积血栓发生率TPO-RA组57% vs 非TPO-RA组36%,事件多集中在术后3个月内启动TPO-RA时。两组出血和死亡率无显著差异。
要点
- 脾切除术后使用TPO-RA与血栓风险增加无显著关联,但10年累积发生率数值上更高(57% vs 36%)。
- 血栓事件多集中在脾切除术后3个月内启动TPO-RA的时期,以静脉事件为主,动脉事件罕见。
- 两组出血和死亡率无显著差异,血小板计数本身不独立影响出血或血栓。
核心结论
- 脾切除术后使用TPO-RA与血栓风险增加无显著关联,但早期启动可能恰逢高风险期,随访期间累积发生率的持续数值差异提示潜在临床相关性。
- 这些发现支持需要个体化血栓预防以及在该情境下对TPO-RA安全性进行前瞻性评估。
研究设计与样本
- 回顾性队列研究,纳入2011年至2024年间接受脾切除术的成人ITP患者88例,根据脾切除术后是否使用TPO-RA进行分层。
- 主要结局为血栓发生率,次要结局包括出血、死亡率和血液学反应,采用时间-事件分析和多因素Cox回归。
主要发现
- 88例患者中37例(42%)在脾切除术后接受TPO-RA治疗。
- TPO-RA组血栓发生17例 vs 非TPO-RA组14例(P=0.07)。
- 10年累积血栓发生率TPO-RA组57% vs 非TPO-RA组36%,数值上更高,事件集中在脾切除术后3个月内启动TPO-RA的时期。
- 血栓以静脉事件为主,动脉事件罕见;两组出血率和死亡率无显著差异。
- 血小板计数本身不独立影响出血或血栓。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immune thrombocytopenia (ITP) carries an increased risk of thrombosis, which may be further amplified by splenectomy and thrombopoietin receptor agonists (TPO-RAs). Although each intervention has been individually studied for its thrombotic risk, data are lacking on the safety of postsplenectomy TPO-RA use. We conducted a retrospective cohort study of adult patients with ITP who underwent splenectomy between 2011 and 2024. Patients were stratified on the basis of postsplenectomy TPO-RA use. The primary outcome was incidence of thrombosis. Secondary outcomes included bleeding, mortality, and hematologic response. Time-to-event analyses and multivariate Cox regression were performed. Among 88 patients, 37 (42%) patients received TPO-RAs after splenectomy. Thrombosis occurred in 17 patients in the TPO-RA group vs 14 patients in the non-TPO-RA group (P = .07). The 10-year cumulative incidence of thrombosis was numerically higher in the TPO-RA group (57% vs 36%), with clustering of events within the 3 months of postsplenectomy TPO-RA initiation. Venous events predominated; arterial events were rare. No significant differences were observed in bleeding or mortality rates between groups. Platelet counts alone did not independently affect bleeding or thrombosis. TPO-RA use after splenectomy was not significantly associated with increased thrombosis risk. However, early initiation may coincide with a high-risk period, and the sustained numerical difference in cumulative incidence throughout follow-up highlights potential clinical relevance. These findings support the need for individualized thromboprophylaxis and prospective evaluation of TPO-RA safety in this setting.
引用
- Alyamany R, Houghton DE, Sridharan M, et al. Beyond platelet counts: assessing safety of postsplenectomy TPO-RA use in ITP. Blood Adv. 2025. PMID: 40875595. doi:10.1182/bloodadvances.2025017902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。